Get the full picture
Sign in to uncover key details.
HighTide Therapeutics
Manufacturing · Maryland, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
11140 Rockville Pike Ste 100-551, Rockvi...Phone Number
+61 414668863Website
www.hightidetx.comRevenue
$14.8 MillionIndustry
About HighTide Therapeutics
HighTide Therapeutics, Inc. is focused on developing innovative therapeutic solutions for chronic metabolic diseases, particularly those related to cardiovascular-kidney-metabolic (CKM) conditions. Their lead candidate, HTD1801, targets diseases driven by insulin resistance and chronic inflammation. The company also has a growing discovery portfolio aimed at addressing unmet needs in this area. HighTide Therapeutics is dedicated to advancing treatments that improve patient outcomes in chronic metabolic diseases.Explore more
HighTide Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to HighTide Therapeutics
Compare insights from companies similar to HighTide Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
HighTide Therapeutics Tech Stack
A closer look at the technologies used by HighTide Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding HighTide Therapeutics
Sign Up For FreeTo access detailed company insights
HighTide Therapeutics, Inc. is focused on developing innovative therapeutic solutions for chronic metabolic diseases, particularly those related to cardiovascular-kidney-metabolic (CKM) conditions. Their lead candidate, HTD1801, targets diseases driven by insulin resistance and chronic inflammation. The company also has a growing discovery portfoli... Read More
